This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

AptarGroup Reports Fourth Quarter And Annual Results; Updates Status Of European Operations Optimization Plan

AptarGroup, Inc. (NYSE:ATR) today reported fourth quarter and annual results. The Company also updated the status of its previously announced plan to optimize certain European operations.

Fourth Quarter 2012 Summary

  • Reported sales increased 5% (core sales increased 2% excluding currency and acquisition effects)
  • Growth in the beauty, personal care, and beverage markets offset the anticipated softness in the generic allergy treatment market
  • Latin America and Asia sales growth remained strong
  • Reported earnings per share of $0.52 included the negative impact of $0.05 per share from charges related to the European Operations Optimization plan
  • Aptar Stelmi contributed $0.03 to earnings per share
  • Earnings were positively impacted by tax related items of $1.3 million, or approximately $0.02 per share
  • Quarterly dividend increased 14% to $0.25 per share

FOURTH QUARTER RESULTS

For the quarter ended December 31, 2012, reported sales increased 5% to $571 million from $545 million a year ago. Recently acquired Aptar Stelmi contributed approximately $31 million or 6% to the quarterly sales growth. Changes in currency exchange rates negatively impacted sales by approximately 3%.

 
Fourth Quarter Segment Sales Analysis

(Change Over Prior Year)

 
    Beauty +    

 

    Food +     Total
Home    

Pharma

    Beverage     AptarGroup
Core Sales 3 % -4 % 9 % 2 %
Currency Effects -3 % -2 % -1 % -3 %
Acquisitions       23 %           6 %
Total Reported Growth 0 %     17 %     8 %     5 %
 




1 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,070.40 +46.34 0.26%
S&P 500 2,114.49 +6.20 0.29%
NASDAQ 5,016.9290 +11.5380 0.23%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs